Reply to Skokou, M. Comment on "Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158"

Nutrients. 2022 May 19;14(10):2119. doi: 10.3390/nu14102119.

Abstract

In response to our narrative review, which suggested the use of the glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a potential treatment for anorexia nervosa (AN) [...].

Publication types

  • Review

MeSH terms

  • Anorexia Nervosa* / drug therapy
  • Humans
  • Ketamine* / therapeutic use
  • Nutrients

Substances

  • Ketamine
  • Nutrients